I n the early 1980s, clinical laboratories introduced robotics. nowadays, automation is commonly increasing in agricultural, food, environmental analytical, and pharmaceutical labs. [1] [2] [3] [4] considering the need to free human resources, minimize errors, improve reproducibility, increase the throughput, reduce reagent costs, and test compounds, the introduction of highthroughput screening (hts) has led to the development of robotic systems that fully automate liquid handling. 5, 6 although tabletop automated liquid handling and sample dispensing systems are nowadays becoming routine in most life science laboratories, there are still some barriers that prevent users from changing to automated configurations (e.g., lack of time, investment money, and personnel training time). in addition, ambitious goals and time-dependent projects detain researchers from continually evaluating automated liquid handlers for characteristics such as precision, accuracy, efficiency, and reproducibility. 7, 8 health care benefits today have improved from the use of both natural and synthetic biomaterials, which are developed as scaffolds for tissue engineering (te) or other applications in regenerative medicine. 9, 10 according to a series of normative rules, internationally established materials that can be used for biomedical applications must be evaluated for their biocompatibility. because biocompatibility is related to a specific area and function in the human body, it is not possible to analyze biocompatibility in vitro. 11 however, several in vitro assays can be performed to assess the general cytocompatibility or cytotoxicity of a given cell type in combination with given biomaterials. such in vitro assays include cell adhesion, cell morphology, viability, proliferation, and cell death. as the toxic effect of biomaterials on cells is considered one of the most important issues to be evaluated, large-scale cell-based screening studies are now starting to be applied in the biomaterial field. 12, 13 the term cell-based assay describes any procedure that uses viable cells for evaluation of effects on toxicity, viability, proliferation, or other specific cellular processes following the addition of a test compound. 5, 14 traditionally, the process of performing a cell-based assay includes seeding cells, equilibrating cells to culture conditions, adding a test compound, and finally measuring the output (e.g., metabolic activity). thus, adaptation of both single-and multiple-step assays to an automated workstation implies that they are homogeneous, reliable, reproducible, sensitive, safe, cost-effective, efficient, and robot friendly (e.g., avoiding preincubation) and allow for miniaturization to at least 96-well formats without negative effects on reproducibility, robustness, and statistical significance of the results. 5, 15 numerous attempts have been made to achieve miniaturization of cell-based screening assays. [16] [17] [18] importantly, biomaterial discovery is frequently not a linear process but instead an iterative process consisting of the screening of numerous possible combinations. biomaterial arrays are now increasingly used to systematically investigate cell-biomaterial interactions. [19] [20] [21] in our previous work, we have established a grid-based platform to investigate stem cellbiomaterial interactions for te. More than 140 combinations of different cell types and different polymers were assessed by systematic screenings, including analyses of parameters such as cell morphology, vitality, proliferation, cytotoxicity, and apoptosis. 22 in our present study, we aim at establishing cell-based protocols for automated and standardized means to perform laborious toxicity screening work. therefore, the adaptation of three different cell-based assays-viability, cytotoxicity, and apoptosis-on the epMotion 5070 liquid handling station (lhs) was a major goal of this work. We also demonstrate that these multiplexed cell-based assays can be optimized in a modern automated system to provide a viable tool to investigate in vitro compatibility and toxicity of biomaterials for animal cells without negative effects on the screening effectiveness/efficiency.
MAterIALS And MethodS

EpMotion 5070 mixing tool optimization
an l929 cell solution (3.3 × 10 5 cells/ml in 100 µl/well) was automatically seeded in a 96-well microplate using the epMotion 5070 lhs (eppendorf, hamburg, Germany) both with and without using the mixing command (mix before aspirating, 3×, 300 µl, 5 mm/sec). First, 100 µl medium for background control was transferred from the medium reservoir to the first column of the 96-well microplate (eight-channel tool, 300-µl tips, reagent transfer command, multidispensing), followed by the transfer of 100 µl cell solution from the cell solution reservoir to the remaining wells of the 96-well microplate (eightchannel tool, 300-µl tips, reagent transfer, multidispensing). after 24 h of incubation, cell viability was quantified by the celltiter-blue cell Viability assay (Promega, Mannheim, Germany) according to the automated viability protocol described next. Fluorescence intensity was measured at λ = 560 ex /590 em using a plate fluorometer FlUostar oPtiMa (bMG labtech, Jena, Germany).
EpMotion 5070 accuracy evaluation
two hundred microliters of l929 cell solution (2.03 × 10 6 cells/ml in 100 µl/well) was transferred from the reservoir to the first column of a 96-well microplate (eight-channel tool, 300µl tips, reagent transfer command, mix before aspirating), followed by the addition of 100 µl medium to all remaining 11 columns (eight-channel tool, 300-µl tips, reagent transfer command, multidispensing); 100 µl was then transferred from one column to the following, starting on column 1 to column 11 (eight-channel tool, 300-µl tips, dilute command, mix before aspirating, change tips before each aspiration, dispense from top). simultaneously, a traditional manual 10-to 100-µl eightchannel pipette (eppendorf, hamburg, Germany) was used to seed an l929 cell solution (2.03 × 10 6 cells/ml in 100 µl/well) on a 96-well microplate and then progressively diluted from columns 1 to 10 in a pattern allowing one to obtain a dilution from 1:2 to 1:512. column 12 was used for background control (cell culture medium only). after 24 h of incubation (37 °c, 20% o 2 , 5% co 2 ), fluorescence was determined by the celltiter-blue cell Viability assay. Fluorescence intensity was measured using the fluorometer FlUostar oPtiMa at λ = 560 ex /590 em .
Automated viability quantification
a group of sequential steps was adapted to the epMotion 5070 lhs according to the following: first discard 100 µl spent culture medium from each well of the cultured plate to an empty reservoir (eight-channel tool, 300-µl tips, pool to one destination command, changing tips before each aspiration); then add 100 µl fresh medium from one reservoir to each well of the cellcontaining plate (eight-channel tool, 300-µl tips, reagent transfer, multidispensing) followed by transferring 20 µl viability reagent from one reservoir to each well of the plate (eightchannel tool, 300-µl tips, reagent transfer, multidispensing). afterwards, the user had to transfer the cell plate to a 37 °c incubator with 20% o 2 and 5% co 2 (user intervention command, alarm on, comment) for a 60-min incubation period (wait command, 60 min). When the incubation was finished, the user transferred the cell plate from the 37 °c incubator back to the epMotion 5070 worktable (user intervention command, alarm on, comment), followed by the transfer of 90 µl supernatant from each well of this plate to each corresponding well on a black 96-well plate (eight-channel tool, 300-µl tips, sample transfer command, changing tips before each aspiration). at the end, the user had to measure fluorescence (user intervention command, alarm on, comment). Fluorescence intensity was determined at λ = 560 ex /590 em using a plate fluorometer FlUostar oPtiMa (bMG labtech).
Comparison of cell seeding performances
Four different pipetting/dispensing methods were evaluated: (1) an epMotion 5070 lhs (eppendorf), (2) a Plate Fill liquid dispenser (cybio, Jena, Germany), (3) a manual eight-channel pipette (eppendorf), and (4) a one-channel pipette (eppendorf). First, precision and reproducibility of experiments, including biological variation, were directly compared. l929 cells were cultured for 5 days and then automatically seeded into a 96-well microplate, at a cell density of 3.316 × 10 5 cells/ml in 100 µl/ well. the same density was used for the cell seeding procedures (2) to (4) . number of viable cells was assessed 24 h after cell seeding using the celltiter-blue cell Viability assay (Promega) according to the automated viability protocol described above. Velocity of cell seeding was an additional parameter measured. second, the same setting was used to evaluate the precision achieved by each of the four methods. to determine pipetting accuracy without any biological variation, a dye solution of 10% Ponceau s (serVa, heidelberg, Germany) in acetic acid (5% v/v) was measured instead of a cell solution, and no incubation steps were performed. absorbance was determined at λ = 590 nm using a photometric plate reader (biorad, München, Germany).
Automated multiplexed cell-based protocol development
Biomaterial preparation. biomaterial synthesis was performed as previously described. 22 briefly, collagen was obtained by mixing 80% collagen-G (4 mg/ml; biochrom aG, berlin, Germany), 10% Dulbecco's modified eagle's medium (DMeM; 10×; biochrom aG), and 10% rPMi 1640 medium (Gibco, Karlsruhe, Germany). this mixture was neutralized with 1 M naoh, and then 10 µl/well was pipetted to the 96-well microplate and stored in a 37 °c incubator overnight for collagen polymerization. two commercial membranes, hybond-c super and hybond-n (both amersham life science, buckinghamshire, UK), were used for the experiments acting as pure nitrocellulose and nylon, respectively. small circles (radius = 5 mm) were cut from both of the 0.45-µm-thick membranes using a sterile tool; subsequently, membranes were washed under sterile conditions with aqua ad injectabilia (Deltaselect, Pfullingen, Germany) and dried overnight.
Cell seeding. an l929 cell solution (5 × 10 4 cells/ml at 100 µl/well) was prepared and supplied to the epMotion 5070 lhs. automated cell seeding was performed 24 h before starting the multiplex analysis according to the following plate configuration: column 1, background (medium only); column 3, untreated control (only cells); column 5, collagen-G/l929 cells; column 7, pure nitrocellulose/l929 cells; column 9, nylon/l929 cells; column 11, apoptotic cells (l929 cells; staurosporine 2 µM; 5-h preincubation); and column 12, toxic cells (l929 cells; lysis solution; 10-min preincubation).
Multiplex cell-based assay. the concept of assay multiplexing is demonstrated in this work by using a combination of three commercially available kits: the celltiter-blue cell Viability assay, the cytotox-one homogeneous Membrane integrity assay, and the apo-one homogeneous caspase 3/7 assay (all Promega). Development of the automated protocol included translation of individual protocol requirements of all three cell-based assays into a single automated optimized protocol (table 1) . the deck layout is depicted in table 2, and the automated multiplexed procedure consisted of the transfer of 90 µl of supernatant from each well of the cell plate to corresponding wells of the black 96-well plate to perform the cytotoxicity assay (eightchannel tool, 300-µl tips, sample transfer command, changing tips before each aspiration, dispense from top), and then 10 µl of remaining medium was discarded from each well of the cell plate to empty reservoir 7 (eight-channel tool, 300-µl tips, pool to one destination command, changing tips before each aspiration). afterward, 100 µl of new medium was transferred from reservoir 1 to each well of the cell plate (eight-channel tool, 300-µl tips, reagent transfer command, multidispensing), and then 20 µl of viability reagent was transferred from reservoir 2 to each well of the cell plate (eight-channel tool, 300-µl tips, reagent transfer command, multidispensing). next, the user had to transfer the cell plate from the worktable to a 37 °c incubator with 20% o 2 and 5% co 2 (user intervention command, alarm on, comment). ninety microliters of cytotoxicity reagent from reservoir 3 was subsequently transferred to corresponding wells of the black 96-well plate already containing supernatant at a2 (eight-channel tool, 300-µl tips, reagent transfer command, multidispensing, dispense from top), and a 10-min incubation period was required (wait command, 10 min). Following a transfer of 45 µl of cytotoxicity stop solution from reservoir 4 to each well of the black 96-well plate at a2 (8-channel tool, 300 µl tips, reagent transfer command, multidispensing, dispense from top), the user had to measure cytotoxicity (user intervention command, alarm on, comment). Fluorescence intensity was determined at λ = 560 ex /590 em using the fluorometer FlUostar oPtiMa (bMG labtech). a waiting period of 40 min for viability incubation was left (wait command, 40 min), and afterward the user was required to transfer the cell plate from the incubator to position b2 of the epMotion 5070 lhs worktable. in addition, the user had to provide a new black 96-well plate at position a2 (user intervention command, alarm on, comments). then, 90 µl of supernatant from each well of the cell plate was transferred to each well of the black 96-well plate to perform the viability measurement (eight-channel tool, 300-µl tips, sample transfer command, changing tips before each aspiration, aspirate from top). a user intervention was required next to measure viability (fluorescence intensity was determined at λ = 560 ex /590 em ), and again the user had to provide a new black 96-well plate at position a2 (user intervention command, alarm on, comments). next, 30 µl of the remaining medium was discarded from each well of the cell plate to the empty reservoir 7 (eight-channel tool, 300-µl tips, pool to one destination command, changing tips before each aspiration), followed by the addition of 25 µl new medium from reservoir 1 to each well of the cell plate (eight-channel tool, 300-µl tips, reagent transfer command, multidispensing). after that, 25 µl of apoptosis reagent from reservoir 5 was transferred to each well of the cell plate (eight-channel tool, 300-µl tips, reagent transfer command, multidispensing, dispense from the top). this was followed by a 120-min incubation period (wait command, 90 + 30 min). after incubation, 50 µl of supernatant from each well of the cell plate was transferred to each of the corresponding wells of the black 96-well plate to determine apoptosis (eightchannel tool, 300-µl tips, sample transfer command, changing tips before each aspiration), and finally the user had to measure apoptosis (user intervention command, alarm on, comment). Fluorescence intensity was determined using the fluorometer FlUostar oPtiMa (bMG labtech) at λ = 485 ex /520 em .
Manual multiplexed cell-based protocol. the multiplex method was completely done manually in parallel using an eight-channel pipette (eppendorf) to compare the data (automated vs. manual). both methods, automated and manual, were repeated at three different time points of the cell growth for each experimentday 1 (lag phase), day 5 (exponential phase), and day 7 (stationary phase)-to test whether influence of biological variation on pipetting errors may vary during cell proliferation.
Automated multiplexed cell-based protocol implementation. an easy-to-understand and user-friendly manual was prepared by the first author of this manuscript (available on request). it contains general information on the lhs, general information on the cell-based assays, and a quick-start chapter describing the method. laboratory members were asked to perform a standard protocol after reading the quick introduction chapter. intentionally, the randomly chosen staff people had different scientific backgrounds, different ages and genders, and different familiarity with both the lhs instrumentation and the cell-based assays.
Data analysis. all data were normalized to standardize fluorescence values. student t test and analysis of variance (anoVa) were performed as indicated using Microsoft excel (Microsoft, redmond, Wa) and GraphPad Prism (GraphPad software, san Diego, ca) software packages.
reSuLtS
Automated mixing improves pipetting precision and reproducibility of cell-based samples
When using cells in culture, it is well recognized that one of the drawbacks is that cells undergo unpredictable alterations under in vitro conditions mostly due to the heterogeneous character of the cell solutions. in fact, different cultures of primary cells may show different sensitivities. 23 our first experiment aimed at optimizing the technical issues related to the pipetting/dispensing tools used because the biological issues that naturally affect data reproducibility cannot be controlled. Using the mixing function of the lhs greatly improved the reproducibility of replicate cell seeding into 96-well plates by reducing the variation of the normalized mean cell fluorescence from 103% ± 16% without mixing to 97% ± 5% with mixing (p = 2.52 × 10 −9 ; n = 264). in addition, other automated parameters such as type of liquid (water-based solution), number of cycles (three), amount mixed (300 µl), and pipetting speed (5 mm/sec) were optimized.
EpMotion 5070 LHS pipetting has higher accuracy and reproducibility compared to manual pipetting techniques
experiments of cytotoxicity testing of biomaterials are usually affected by different types of variation. it is essential to remember that the cell behavior, together with the chemical biomaterial influence, will both generate a cell/biomaterial-specific interaction that, depending on the microenvironment conditions, will determine the cytotoxic level of the tested material. 24 in addition, it is very important to quantify the variation contributed by technical issues to better understand the biomaterial effect on the cells. automated dilution by lhs was compared to manual dilutions using an eight-channel pipette to determine the precision, reproducibility, and accuracy levels obtained by both methods. Figure 1 illustrates that the accuracy of the lhs was higher than the manual pipetting because real concentrations obtained were closer to theoretical values (a dilution factor of 0.5 was expected). statistical analysis of successive dilutions showed that the lhs versus the manual eight-channel pipetting had dilution factors of 0.53 ± 0.1 versus 0.64 ± 0.26 (p = 1.12 × 10 −8 , n = 216), thus confirming that the lhs was more accurate.
Biological variation is significantly smaller using the EpMotion 5070 LHS compared to three other pipetting/dispensing methods
choosing the right pipetting technique for a certain type of sample and application is crucial in terms of eliminating inaccurate results. a large number of different devices for sample preparation are currently available on the market. 8 in general, one can distinguish between pipettes, dispensers, and multifunctional automated dispensers. to identify the pipetting/dispensing device best suited for dispensing cell suspensions, four methods were compared. the epMotion 5070 lhs had a liquid pipetting error of 2%, matching the manufacturer's technical specifications. 25 this increased to 9% when cell suspension was dispensed. the corresponding values for liquid and cell suspension dispensing were 8% and 32%, respectively, with the Plate Fill liquid dispenser machine; 2% and 20%, respectively, with the manual eight-channel pipette; and 3% and 12%, respectively, with the manual one-channel pipette. thus, cell dispensing by lhs was more accurate and more reproducible than with the Plate Fill, eight-channel pipette, or one-channel pipette. Figure 2 summarizes operator time and operator activity required for one assay cycle. the biggest advantage of the semi-automated methods (Plate Fill and lhs) is the low amount of operator activity required with an ensuing increase in reproducibility and accuracy due to less operator errors. the operator time required for each cycle is similar for semi-automated and eight-channel methods but is superior in terms of fatigue for the semi-automated methods and even more so for lhs with increasing cycle numbers. thus, lhs is the preferred method for semiautomated cytotoxicity screening of a cell-biomaterial interaction typically involving three cycles of 96-well plate testing.
Automated platform improves the performance of a multiplex cell-based protocol for toxicity testing of biomaterials
by combining different cell-based assay chemistries with the epMotion 5070 lhs, an automated method for simultaneous analysis of three different cell parameters (viability, cytotoxicity, and apoptosis) in a 96-well microplate containing cell/biomaterials constructs was established. Figure 3 summarizes the results of a typical experiment. three different stages of cell growth were analyzed: D3 cells (lag phase), D5 cells (exponential phase), and D7 cells (stationary phase). the lag phase of cell growth corresponds to a period of cell adaptation to the new conditions in the 96-well microplate. cell behavior at this stage is very variable because it depends on several factors, such as age of cells (number of passages), exterior conditions (temperature and air circulation), and media composition. D7 cells are metabolically less active, and proliferation has stopped. in contrast, the highly proliferating D5 cells are most vulnerable to toxic effects and therefore should be the preferred choice for assays of cell-biomaterial interaction.
this experiment demonstrates that the percentages of viable, necrotic (cytotoxicity signal), and apoptotic cells detected on tissue culture plastic (tcPs) are comparable between automated experiments and manual experiments. automated assay controls for cytotoxicity and apoptosis are as valid as the manual ones (data not shown), thus proving that automation does not affect assay validity.
outlier values are boxed (7 of 108 in Fig. 3A and 13 of 108 in Fig. 3B ) and indicate the combined variability caused by the operator and instrument error and by inherent biological variability. the fact that the lhs method had fewer outliers demonstrates that this method is superior to manual testing. Variability can be further averaged out by increasing the number of replicates, which would also argue in favor of the lhs.
Using the protocol described above, the setup time spent by various users, including untrained students, medical and biological researchers, and trained technicians, ranged from 5 to 13 min. this short time compared very favorably with hours or even days usually required to train users on more automated but also more complex large-scale robotic handling systems. this finding was fully confirmed when the lhs assay was offered as a major part of the Marie curie Practical training course on "tissue engineering, stem cells and biocompatibility testing of biomaterials," organized by the Department of biomedical engineering-biointerface laboratory of rWth aachen University in Germany. the event was part of a series of events held by the inVents project consortium, "an integrated series of events for high-level training on biomaterials, tissue engineering, controlled Drug Delivery and related emerging Fields." Funding was provided by the european Union (Marie curie actions/FP6/hrM). During this course, 25 participants from 11 european and overseas countries performed with virtually no previous knowledge of robotic liquid handling the described cytocompatibility test with good success. dIScuSSIon according to the German international standardization organization rule, Din-iso 10993-5, both qualitative and quantitative analyses of biocompatibility testing are required. Qualitative analyses are based on the morphological examination of cell damage and growth, whereas quantitative analyses may be based on measurements of metabolic activity after a period of direct or indirect cell contacts with the materials. 26, 27 so far, there is no way of predicting cell behavior on given biomaterials that could reliably identify suitable biomaterials for specific applica-tions. iterative testing must be applied. 22, 24 hence, standardized protocols for automated cytocompatibility screenings of biomaterials will be a valuable help for low-to medium-throughput laboratories performing such analyses.
high-throughput testing in biomaterials research has not had the same impact as in pharmacology, for example. a thorough discussion of past and current developments in the field is given by Power and colleagues. 13 of high importance in the field of automated toxicity screening is the fact of sample pipetting being severely affected by two main types of errors: random or systematic errors derived from technical issues 28 and derived from biological issues. by comparing three traditional pipetting/dispensing methods (manual one-channel pipette, manual eight-channel pipette, and a liquid dispenser machine) to the automated epMotion 5070 lhs, it was our aim to minimize pipetting errors derived from biological causes to achieve accurate and reliable measurements. one could not only achieve more accurate and reproducible results by using the lhs system instead of the other three methods but also minimize errors of samples, including biological variations.
although nowadays, mechanical manual pipettes are the standard equipment of traditional laboratories, automated platforms are becoming more widely accepted in laboratories of all sizes. 3, 29 the cost of purchase is approximately 20-fold higher for a small liquid handling station such as the epMotion lhs used here or for similar instruments on the market than for an eightchannel pipette. this is within reach of most biological laboratories and amounts to about one-tenth the cost of a completely automated high-throughput robotic station. the running cost in terms of consumables and reagents is essentially identical for both the eight-channel manual and the automated lhs method. the automated multiplex method described here avoids disadvantages of the more time-consuming and labor-intensive manual work. in summary, our proof-of-principle study demonstrated that (1) automation of cell-based assays can decrease processing time with lower plate-to-plate variation as compared to manual handling; (2) the automatic lhs reduces the workload and improves the accuracy and precision in dispensing, independent of the user; and (3) the cell-based screening assay approach described in this work provides a potential utility in characterizing the compatibility of biomaterials that meet the needs of low-and medium-throughput research laboratories.
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